ACIM
IDXX icon

Azimuth Capital Investment Management’s Idexx Laboratories IDXX Stock Holding History

Azimuth Capital Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17M Sell
30,214
-1,611
-5% -$1.03M 0.64% 41
2025
Q4 		$21.5M Sell
31,825
-137
-0.4% -$93.3K 0.77% 28
2025
Q3 		$20.4M Buy
31,962
+8,212
+35% +$4.98M 0.73% 38
2025
Q2 		$12.7M Sell
23,750
-423
-2% -$202K 0.47% 64
2025
Q1 		$10.2M Buy
24,173
+11,777
+95% +$5.11M 0.4% 83
2024
Q4 		$5.13M Sell
12,396
-799
-6% -$350K 0.2% 138
2024
Q3 		$6.67M Sell
13,195
-4,467
-25% -$2.17M 0.26% 124
2024
Q2 		$8.6M Sell
17,662
-622
-3% -$312K 0.35% 94
2024
Q1 		$9.87M Sell
18,284
-69
-0.4% -$37.7K 0.41% 78
2023
Q4 		$10.2M Sell
18,353
-11,284
-38% -$5.3M 0.46% 77
2023
Q3 		$13M Sell
29,637
-927
-3% -$462K 0.64% 51
2023
Q2 		$15.4M Buy
30,564
+2,555
+9% +$1.22M 0.73% 41
2023
Q1 		$14M Buy
28,009
+7,668
+38% +$3.67M 0.69% 48
2022
Q4 		$8.3M Sell
20,341
-563
-3% -$219K 0.42% 73
2022
Q3 		$6.81M Sell
20,904
-417
-2% -$153K 0.37% 89
2022
Q2 		$7.48M Buy
+21,321
New +$8.69M 0.38% 92

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Azimuth Capital Investment Management's IDXX Position: Q1 2026 in Review

Azimuth Capital Investment Management reduced its Idexx Laboratories (IDXX) stake by 5.1% in Q1 2026, selling an estimated $1.03M and leaving 30,214 shares worth $17M. The position accounts for 0.64% of the portfolio, ranked #41.

Azimuth Capital Investment Management first reported a position in IDXX in Q2 2022 and has held it in 16 quarters since. The position peaked at $21.5M in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Azimuth Capital Investment Management held 30,214 shares of Idexx Laboratories worth $17M as of Q1 2026.
  • Azimuth Capital Investment Management sold 1,611 Idexx Laboratories shares in Q1 2026, an estimated $1.03M.
  • Idexx Laboratories made up 0.64% of Azimuth Capital Investment Management's portfolio in Q1 2026, its #41 holding.
  • Azimuth Capital Investment Management first reported a position in Idexx Laboratories in Q2 2022 and has held it in 16 quarters since.
  • Azimuth Capital Investment Management's Idexx Laboratories position peaked at $21.5M in Q4 2025.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Azimuth Capital Investment Management's 13F filing for Q1 2026, filed 12 May 2026.